To rigorously evaluate the anti-T790M-mutant NSCLC activity of Timosaponin AIII, we performed cell viability analyses using the CCK-8 assay in H1975 cells (EGFR T790M mutant cells). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.